| 2024-09-19 |
[Correspondence] Considerations for future trials in cerebral cavernous malformations |
Ali M Alawieh, Hassan Saad, Jonathan A Grossberg, Daniel L Barrow |
|
| 2024-09-19 |
[Correspondence] Considerations for future trials in cerebral cavernous malformations |
Marco Cenzato, Ulrich Sure, Giuseppe Lanzino, Davide Boeris, Torstein Meling, Luca Regli, Andreas Gruber, Peter Vajkoczy, Michael Lawton |
|
| 2024-09-19 |
[Correspondence] RAB32 mutation in Parkinson's disease |
Yuwen Zhao, Hongxu Pan, Jifeng Guo, Beisha Tang, Zhenhua Liu |
|
| 2024-09-19 |
[Correspondence] RAB32 mutation in Parkinson's disease – Author's reply |
Matthew J Farrer |
|
| 2024-09-19 |
[Correspondence] RAB32 mutation in Parkinson's disease |
Edoardo Monfrini, Raffaella Minardi, Franco Valzania, Giovanna Calandra-Buonaura, Paola Mandich, Alessio Di Fonzo, ParkNet Study Group |
|
| 2024-09-19 |
[Correspondence] RAB32 mutation in Parkinson's disease |
Pilar Gómez-Garre, Miguel Martín-Bórnez, Pablo Mir |
|
| 2024-09-19 |
[Comment] Diagnosis of multiple sclerosis: challenges and opportunities |
Mitchell Wallin |
|
| 2024-09-19 |
[Correspondence] RAB32 mutation in Parkinson's disease |
Christian Beetz, Mandy Radefeldt, Kornelia Tripolszki, Krishna Kumar Kandaswamy, Peter Bauer, ROPAD Study Group |
|
| 2024-09-19 |
[Comment] Amyloid removal and the appearance of brain volume loss |
Bradley T Hyman |
|
| 2024-09-19 |
[Comment] Targeting auto-antibodies for CIDP: hope and questions |
Yusuf A Rajabally |
|
| 2024-09-19 |
[Comment] Important considerations for children with non-dystrophic myotonia |
Bettina C Henzi, Andrea Klein |
|
| 2024-09-19 |
[Comment] Global burden of stroke: dynamic estimates to inform action |
Simiao Wu, Ming Liu |
|
| 2024-09-19 |
[Correspondence] Considerations for future trials in cerebral cavernous malformations – Authors' reply |
CARE pilot trial collaboration |
|
| 2024-09-19 |
[Personal View] Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and Australasia |
Lilyana Amezcua, Dalia Rotstein, Afsaneh Shirani, Olga Ciccarelli, Daniel Ontaneda, Melinda Magyari, Victor Rivera, Dorlan Kimbrough, Ruth Dobson, Bruce Taylor, Mitzi Williams, Ruth Ann Marrie, Brenda Banwell, Bernhard Hemmer, Scott D Newsome, Jeffrey A C |
|
| 2024-09-19 |
[Personal View] Differential diagnosis of suspected multiple sclerosis: global health considerations |
Jorge Correale, Andrew J Solomon, Jeffrey A Cohen, Brenda L Banwell, Fernando Gracia, Tirisham V Gyang, Fernando Hamuy Diaz de Bedoya, Mary P Harnegie, Bernhard Hemmer, Anu Jacob, Ho Jin Kim, Ruth Ann Marrie, Farrah J Mateen, Scott D Newsome, Lekha Pandit |
|
| 2024-09-19 |
[Editorial] Improving access to medicines for neurological disorders |
The Lancet Neurology |
|
| 2024-09-19 |
[Articles] Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial |
Jeffrey A Allen, Jie Lin, Ivana Basta, Tina Dysgaard, Christian Eggers, Jeffrey T Guptill, Kelly G Gwathmey, Channa Hewamadduma, Erik Hofman, Yessar M Hussain, Satoshi Kuwabara, Gwendal Le Masson, Frank Leypoldt, Ting Chang, Marta Lipowska, Murray Lowe, G |
|
| 2024-09-19 |
[Personal View] Brain volume change following anti-amyloid β immunotherapy for Alzheimer's disease: amyloid-removal-related pseudo-atrophy |
Christopher R S Belder, Delphine Boche, James A R Nicoll, Zane Jaunmuktane, Henrik Zetterberg, Jonathan M Schott, Frederik Barkhof, Nick C Fox |
|
| 2024-09-19 |
[Articles] Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 |
GBD 2021 Stroke Risk Factor Collaborators |
|
| 2024-09-19 |
[Articles] Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial |
Vinojini Vivekanandam, Iwona Skorupinska, Dipa L Jayaseelan, Emma Matthews, Richard J Barohn, Michael P McDermott, Michael G Hanna |
|
| 2024-09-19 |
[In Context] Navigating the roads ahead for Alzheimer's disease |
Robert Stirrups |
|
| 2024-09-19 |
[In Context] On the trail of Edinburgh's neuroscience past and present |
Peter Ranscombe |
|
| 2024-09-19 |
[In Context] Non-inferiority design for trials in multiple sclerosis |
Maria Pia Sormani, Heinz Wiendl |
|
| 2024-09-19 |
[In Context] Shaida Khan |
|
|
| 2024-09-19 |
[In Context] Health as a philosophical idea |
Carlos M Madrid-Casado |
|
| 2024-09-19 |
[In Context] Christopher Ross: diseases of the brain, not the mind |
Ray Cavanaugh |
|
| 2024-09-19 |
[Correspondence] The Yaoundé Declaration |
Alfred K Njamnshi, Agustin Ibanez, Gagandeep Singh, Mika Pyykko, Vladimir Hachinski, Harris A Eyre, Scientific Technical Committee |
|
| 2024-08-15 |
[Review] Intracranial pressure monitoring in adult patients with traumatic brain injury: challenges and innovations |
Tommaso Zoerle, Erta Beqiri, Cecilia A I Åkerlund, Guoyi Gao, Thomas Heldt, Gregory W J Hawryluk, Nino Stocchetti |
|
| 2024-08-15 |
[Editorial] The evolving paradigm of Alzheimer's disease diagnosis |
The Lancet Neurology |
|
| 2024-08-15 |
[Articles] Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial |
Stefan Zielen, Thomas Crawford, Luca Benatti, Mauro Magnani, Matthias Kieslich, Monique Ryan, Isabelle Meyts, Sheffali Gulati, Rupam Borgohain, Ravi Yadav, Pramod Pal, Anaita Hegde, Suresh Kumar, Anand Venkateswar, Vrajesh Udani, Kollencheri P Vinayan, An |
|
| 2024-08-15 |
[Correspondence] Ageing and dementia in India |
Thomas Gregor Issac |
|
| 2024-08-15 |
[In Context] Globally advancing neurological education in headache |
Daniele Martinelli, Massimo Leone, Rami Burstein, Augustina Charway-Felli, Cristina Tassorelli |
|
| 2024-08-15 |
[Corrections] Correction to Lancet Neurol 2024; 23: 852–53 |
|
|
| 2024-08-15 |
[In Context] Angela Dos Santos |
|
|
| 2024-08-15 |
[In Context] Lenin's cause of death |
Antonio Perciaccante, Saudamini Deo, Andreas G Nerlich, Philippe Charlier, Raffaella Bianucci |
|
| 2024-08-15 |
[In Context] Parkinson's disease is not just a tremor |
Jules Morgan |
|
| 2024-08-15 |
[In Context] Andrew Singleton: from small island to “Disneyland for doctors” |
Udani Samarasekera |
|
| 2024-08-15 |
[Correspondence] A proposal for equity neuroscience |
Bruce Ovbiagele |
|
| 2024-08-15 |
[Comment] Lessons from the ATTeST trial in ataxia telangiectasia |
Yuka Koike, Osamu Onodera |
|
| 2024-08-15 |
[Correspondence] A biobank for Parkinson's disease and atypical parkinsonism in central Asian and Transcaucasian regions |
Central Asian and Transcaucasian Parkinson's Disease Consortium, Rauan Kaiyrzhanov |
|
| 2024-08-15 |
[Correspondence] Pragmatic outcomes for stroke research |
Johanna M Ospel, Aravind Ganesh, Mayank Goyal |
|
| 2024-08-15 |
[Correspondence] Rare diseases: we need to think about climate change too |
Diana Perry, Anna Mavrogianni, Clare Pelham, Sanjay M Sisodiya |
|
| 2024-08-15 |
[In Context] Neurology and opera |
Eckart Altenmüller |
|
| 2024-08-15 |
[Correspondence] Continuous subcutaneous levodopa–carbidopa infusion for Parkinson's disease – Authors' reply |
Alberto J Espay, Olivier Rascol |
|
| 2024-08-15 |
[Correspondence] Continuous subcutaneous levodopa–carbidopa infusion for Parkinson's disease |
Harmen R Moes, Erik Buskens, Teus van Laar |
|
| 2024-08-15 |
[Correspondence] Continuous subcutaneous levodopa–carbidopa infusion for Parkinson's disease |
Shu Wang, Yin Jiang, Anchao Yang, Fangang Meng, Jianguo Zhang |
|
| 2024-08-15 |
[Comment] Improving thrombolysis efficiency for acute ischaemic stroke |
Vignan Yogendrakumar, Longting Lin, Robert L Medcalf, Mark W Parsons |
|
| 2024-08-15 |
[Comment] Amyloid β, γ-secretase, and familial Alzheimer's disease |
Marie-Claude Potier, Harald Steiner, Lucía Chávez-Gutiérrez |
|
| 2024-08-15 |
[Articles] γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS) |
Stephanie A Schultz, Lei Liu, Aaron P Schultz, Colleen D Fitzpatrick, Raina Levin, Jean-Pierre Bellier, Zahra Shirzadi, Nelly Joseph-Mathurin, Charles D Chen, Tammie L S Benzinger, Gregory S Day, Martin R Farlow, Brian A Gordon, Jason J Hassenstab, Cliffo |
|
| 2024-08-15 |
[Articles] Endovascular thrombectomy for acute ischaemic stroke with established large infarct (TENSION): 12-month outcomes of a multicentre, open-label, randomised trial |
Götz Thomalla, Jens Fiehler, Fabien Subtil, Susanne Bonekamp, Anne Hege Aamodt, Blanca Fuentes, Elke R Gizewski, Michael D Hill, Antonin Krajina, Laurent Pierot, Claus Z Simonsen, Kamil Zeleňák, Rolf A Blauenfeldt, Bastian Cheng, Angélique Denis, Hannes D |
|
| 2024-08-15 |
[Comment] Endovascular thrombectomy for large ischaemic stroke: outcomes beyond 90 days |
Takeshi Morimoto, Fumihiro Sakakibara |
|
| 2024-08-15 |
[Articles] Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study |
Leonard H van den Berg, Jeffrey D Rothstein, Pamela J Shaw, Suma Babu, Michael Benatar, Robert C Bucelli, Angela Genge, Jonathan D Glass, Orla Hardiman, Vincenzo Libri, Theodore Mobach, Björn Oskarsson, Gary L Pattee, John Ravits, Christopher E Shaw, Mark |
|
| 2024-08-15 |
[Comment] Targeting C9orf72 in people with ALS |
Susanne Petri |
|
| 2024-08-15 |
[Correspondence] World Brain Day 2024: a focus on brain health and prevention |
Wolfgang Grisold, David W Dodick, Alla Guekht, Steven L Lewis, Tissa Wijeratne |
|
| 2024-08-15 |
[Review] Sleep and sleep disorders in people with Parkinson's disease |
Alex Iranzo, Valerie Cochen De Cock, María Livia Fantini, Laura Pérez-Carbonell, Lynn Marie Trotti |
|
| 2024-08-15 |
[Articles] Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3, multicentre, open-label, randomised controlled trial in the Netherlands |
Ilse Huijberts, Florentina M E Pinckaers, Susanne G H Olthuis, Sander M J van Kuijk, Alida A Postma, Hieronymus D Boogaarts, Yvo B W E M Roos, Charles B L M Majoie, Aad van der Lugt, Diederik W J Dippel, Wim H van Zwam, Robert J van Oostenbrugge, MR CLEAN |
|
| 2024-08-15 |
[Comment] Durable benefit of thrombectomy 6–24 h after stroke onset |
Bruce C V Campbell |
|
| 2024-07-18 |
[Correspondence] On the new President of the ILAE – Reply by the ILAE |
J Helen Cross |
|
| 2024-07-18 |
[Personal View] Detecting awareness after acute brain injury |
Karnig Kazazian, Brian L Edlow, Adrian M Owen |
|
| 2024-07-18 |
[Corrections] Correction to Lancet Neurol 2024; 23: 393–403 |
|
|
| 2024-07-18 |
[Editorial] A real chance to reduce death and disability from stroke |
The Lancet Neurology |
|
| 2024-07-18 |
[Correspondence] Dietary intervention for post-stroke dysphagia – Authors' reply |
Bendix Labeit, Emilia Michou, Michaela Trapl-Grundschober, Sonja Suntrup-Krueger, Paul Muhle, Philip M Bath, Rainer Dziewas |
|
| 2024-07-18 |
[Correspondence] Azathioprine and mycophenolate mofetil in myasthenia gravis – Authors' reply |
Pushpa Narayanaswami, Donald B Sanders |
|
| 2024-07-18 |
[Correspondence] Dietary intervention for post-stroke dysphagia |
Akio Shimizu, Kohei Yamaguchi, Kenjiro Kunieda, Tomohisa Ohno, Ichiro Fujishima |
|
| 2024-07-18 |
[Correspondence] Azathioprine and mycophenolate mofetil in myasthenia gravis |
Claudia Vinciguerra, Giammarco Milella, Roberto Monastero, Filippo Brighina, Vincenzo Di Stefano |
|
| 2024-07-18 |
[Comment] Cognitive function in people with functional seizures |
Markus Reuber |
|
| 2024-07-18 |
[Comment] Detection of awareness after brain injury: time for change |
Virginia Newcombe |
|
| 2024-07-18 |
[Correspondence] Clinical versus biomarker-based diagnosis of neurocognitive disorders |
Günter U Höglinger, Adam L Boxer, Anthony E Lang |
|
| 2024-07-18 |
[Correspondence] Clinical versus biomarker-based diagnosis of neurocognitive disorders – Authors' reply |
Federico Massa, Nicolas Villain, Matteo Cotta Ramusino, Giovanni B Frisoni |
|
| 2024-07-18 |
[In Context] Tofersen for SOD-1-associated amyotrophic lateral sclerosis |
Marion Haberkamp, Georgios Aislaitner, Elena H Martínez-Lapiscina, Martina Weise |
|
| 2024-07-18 |
[Corrections] Correction to Lancet Neurol 2024; 23: 807–15 |
|
|
| 2024-07-18 |
[In Context] Nazia Karsan |
|
|
| 2024-07-18 |
[In Context] Thinking of epilepsy as a symptom |
Jimmy Li, Gagandeep Singh, Mark R Keezer, Josemir W Sander, SdHIELD Research Group |
|
| 2024-07-18 |
[In Context] Ezio Giacobini: a leader in Alzheimer's disease research |
Avi Ohry |
|
| 2024-07-18 |
[In Context] Women in Neurosurgery: breaking barriers |
Nina Yoh, Sharona Ben-Haim |
|
| 2024-07-18 |
[Correspondence] On the new President of the ILAE |
Robert van Voren |
|
| 2024-07-18 |
[Articles] Prognostic value of tissue bridges in cervical spinal cord injury: a longitudinal, multicentre, retrospective cohort study |
Dario Pfyffer, Andrew C Smith, Kenneth A Weber, Andreas Grillhoesl, Orpheus Mach, Christina Draganich, Jeffrey C Berliner, Candace Tefertiller, Iris Leister, Doris Maier, Jan M Schwab, Alan Thompson, Armin Curt, Patrick Freund |
|
| 2024-07-18 |
[Review] Effects of spaceflight on the brain |
Rachael D Seidler, Xiao Wen Mao, Grant D Tays, Tianyi Wang, Peter zu Eulenburg |
|
| 2024-07-18 |
[Comment] Tissue bridge widths and outcome after spinal cord injury |
James Guest |
|
| 2024-07-18 |
[Articles] Bailout intracranial angioplasty or stenting following thrombectomy for acute large vessel occlusion in China (ANGEL-REBOOT): a multicentre, open-label, blinded-endpoint, randomised controlled trial |
Feng Gao, Xu Tong, Baixue Jia, Ming Wei, Yuesong Pan, Ming Yang, Dapeng Sun, Thanh N Nguyen, Zeguang Ren, Francis Demiraj, Xiaoxi Yao, Chenghua Xu, Guangxiong Yuan, Yue Wan, Jianjun Tang, Jing Wang, Yuanfei Jiang, Chaobin Wang, Xiang Luo, Haihua Yang, Rui |
|
| 2024-07-18 |
[Comment] Bailout angioplasty or stenting for large vessel occlusion |
Joanna M Roy, Stavropoula Tjoumakaris |
|
| 2024-07-18 |
[Articles] Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial |
Mark W Parsons, Vignan Yogendrakumar, Leonid Churilov, Carlos Garcia-Esperon, Bruce C V Campbell, Michelle L Russell, Gagan Sharma, Chushuang Chen, Longting Lin, Beng Lim Chew, Felix C Ng, Akshay Deepak, Philip M C Choi, Timothy J Kleinig, Dennis J Cordat |
|
| 2024-07-18 |
[Comment] Tenecteplase versus alteplase in stroke thrombolysis: the last piece of the puzzle? |
Kazunori Toyoda |
|
| 2024-07-18 |
[Articles] Optimal drainage time after evacuation of chronic subdural haematoma (DRAIN TIME 2): a multicentre, randomised, multiarm and multistage non-inferiority trial in Denmark |
Mads Hjortdal Grønhøj, Thorbjørn Søren Rønn Jensen, Rares Miscov, Ann Kathrine Sindby, Birgit Debrabant, Torben Hundsholt, Carsten Reidies Bjarkam, Bo Bergholt, Kåre Fugleholm, Frantz Rom Poulsen, DACSUHS group |
|
| 2024-07-18 |
[Comment] Management of subdural haematoma: optimising drainage |
Amjad Elmashala, Jonathan Rosand |
|
| 2024-07-18 |
[In Context] Caring for the carers: the power of personal stories |
Udani Samarasekera |
|
| 2024-07-18 |
[Articles] Safety and efficacy of active blood-pressure reduction to the recommended thresholds for intravenous thrombolysis in patients with acute ischaemic stroke in the Netherlands (TRUTH): a prospective, observational, cluster-based, parallel-group st |
Thomas P Zonneveld, Sarah E Vermeer, Erik W van Zwet, Adrien E D Groot, Ale Algra, Leo A M Aerden, Kees C L Alblas, Frank de Beer, Paul J A M Brouwers, Koen de Gans, H Maarten A van Gemert, Bart C A M van Ginneken, Gerke S Grooters, Patricia H A Halkes, T |
|
| 2024-07-18 |
[Comment] Challenging the management of blood pressure before intravenous thrombolysis in acute ischaemic stroke |
Verónica V Olavarría |
|
| 2024-06-13 |
[Correspondence] Multiple sclerosis diagnosis: a biologically driven perspective |
Massimo Filippi, Monica Margoni, Maria A Rocca |
|
| 2024-06-13 |
[Personal View] Glioblastoma and brain connectivity: the need for a paradigm shift |
Alessandro Salvalaggio, Lorenzo Pini, Alessandra Bertoldo, Maurizio Corbetta |
|
| 2024-06-13 |
[Correspondence] Concerns with the new biological research criteria for synucleinopathy – Authors' reply |
Tanya Simuni, Lana M Chahine, Daniel Weintraub, Kathleen M Poston, Catherine M Kopil, Billy Dunn, Kenneth Marek |
|
| 2024-06-13 |
[Correspondence] Concerns with the new biological research criteria for synucleinopathy |
Dario Arnaldi, Matteo Pardini, Andrea Chincarini, Valentina Garibotto, Silvia Morbelli |
|
| 2024-06-13 |
[Correspondence] Concerns with the new biological research criteria for synucleinopathy |
Jacques Reis, Christine Tranchant, Roberto G Lucchini, Peter S Spencer |
|
| 2024-06-13 |
[Correspondence] Concerns with the new biological research criteria for synucleinopathy |
Giulia Carli, Stiven Roytman, Nicolaas Ida Bohnen |
|
| 2024-06-13 |
[Correspondence] Concerns with the new biological research criteria for synucleinopathy |
Francisco Escamilla-Sevilla, Eric Freire-Alvarez, Juan C Martínez Castrillo, Álvaro Sánchez Ferro, Diego Santos-García |
|
| 2024-06-13 |
[Correspondence] Concerns with the new biological research criteria for synucleinopathy |
Bradley F Boeve, Albert A Davis, Yo-El Ju, Kejal Kantarci, Wolfgang Singer, Aleks Videnovic, NAPS co-investigators |
|
| 2024-06-13 |
[Correspondence] Concerns with the new biological research criteria for synucleinopathy |
Jennifer G Goldman, Bradley F Boeve, Doug Galasko, James E Galvin, James B Leverenz, John-Paul Taylor |
|
| 2024-06-13 |
[Correspondence] Concerns with the new biological research criteria for synucleinopathy |
Fred B Ketchum, Nathaniel A Chin |
|
| 2024-06-13 |
[Comment] Implementation research: an approach to overcoming the know-do gap |
Lesli E Skolarus, Linda S Williams |
|
| 2024-06-13 |
[Comment] Moving towards a connectomic view of neuro-oncology |
Hugues Duffau, Massimo Filippi |
|
